<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M871</article-id>
      <article-id pub-id-type="publisher-id">molbank-2015-M871</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>4-Chloro-2,3,5-trifluorobenzoic Acid</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Shuitao</given-names>
          </name>
          <xref rid="af1-molbank-2015-M871" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M871" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>Xiaohu</given-names>
          </name>
          <xref rid="af1-molbank-2015-M871" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M871" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Weiyou</given-names>
          </name>
          <xref rid="af1-molbank-2015-M871" ref-type="aff">1</xref>
          <xref rid="af3-molbank-2015-M871" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xia</surname>
            <given-names>Zhengjun</given-names>
          </name>
          <xref rid="af1-molbank-2015-M871" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M871" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Mingguang</given-names>
          </name>
          <xref rid="af1-molbank-2015-M871" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M871" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yang</given-names>
          </name>
          <xref rid="af1-molbank-2015-M871" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M871" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Zaixin</given-names>
          </name>
          <xref rid="af1-molbank-2015-M871" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M871" ref-type="aff">2</xref>
          <xref rid="c1-molbank-2015-M871" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2015-M871"><label>1</label>Yabang Medical Research Institute, Changzhou 213145, China; E-Mails: <email>pharmsyyk71@163.com</email> (S.Y.); <email>xiaohufeng@126.com</email> (X.F.); <email>zhouwy426@cczu.edu.cn</email> (W.Z.); <email>zhengjun_xia@163.com</email> (Z.X.); <email>zmg1997@aliyun.com</email> (M.Z.); <email>15206111910@163.com</email> (Y.C.)</aff>
      <aff id="af2-molbank-2015-M871"><label>2</label>Jiangsu Novel Quinolone Antibacterial Drugs Engineering Research Center, Changzhou 213145, China</aff>
      <aff id="af3-molbank-2015-M871"><label>3</label>Jiangsu Key Laboratory of Advanced Catalytic Materials and Technology, Changzhou University, Changzhou 213164, China</aff>
      <author-notes>
        <corresp id="c1-molbank-2015-M871"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>zaixin_chen@163.com</email>; Tel.: +86-519-8806-8868.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>2015</volume>
      <issue>4</issue>
      <elocation-id>M871</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>05</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A new tetrahalogenated benzoic acid 4-chloro-2,3,5-trifluorobenzoic acid was synthesized from methyl 2,3,4,5-tetrafluorobenzoate via three steps. The structure of the newly synthesized compound was established by FTIR, NMR, MS and elemental analysis.</p>
      </abstract>
      <kwd-group>
        <kwd>4-chloro-2,3,5-trifluorobenzoic acid</kwd>
        <kwd>synthesis</kwd>
        <kwd>amination</kwd>
        <kwd>Sandmeyer reaction</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molbank-2015-M871" sec-type="intro">
      <title>1. Introduction</title>
      <p>2,3,4,5-Tetrahalogenated benzoic acid derivatives are valuable intermediates for the synthesis of medicaments. Some of these compounds are intermediates for antibacterials such as quinolone carboxylic acids [<xref ref-type="bibr" rid="B1-molbank-2015-M871">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2015-M871">2</xref>]. In the course of our research on biologically active compounds, we needed to prepare a synthetic precursor <bold>1</bold>, <italic>i.e.</italic>, 4-chloro-2,3,5-trifluorobenzoic acid. Although fluoroarenes are versatile components of many synthetic biologically active compounds and functional materials, up to now there has been no report of the synthesis of compound <bold>1</bold>.</p>
      <p>For the synthesis of compound <bold>1</bold>, 4-chloro-2,3,5-trifluoro aniline can be chosen as the starting material, followed by diazotization, Grignard reaction and carbonylation, but the yield of Grignard reagent should be low, and the product is difficult to purify for the interference of chloro substituents.</p>
      <p>On the above analysis, methyltetrafluorobenzoate (<bold>2</bold>) was chosen as the reactant, and we need to convert the fluoro at 4-site to chloro. For the strong bond dissociation energies of C&#x2013;F bonds, C&#x2013;F activation is one of the most challenging issues in organic chemistry. However, firstly converting the fluoro to amine provides a convenient method, and then the amine could transform to chloro by diazotization (<xref ref-type="scheme" rid="molbank-2015-M871-sch001">Scheme 1</xref>).</p>
    </sec>
    <sec id="sec2-molbank-2015-M871">
      <title>2. Result and Discussion</title>
      <p>The first step is to transform fluoro to amine, and there are two choices. The first method is converting the fluoro to azido substituent followed by reduction into amino compound, but sodium azide used in the reaction is not safe [<xref ref-type="bibr" rid="B3-molbank-2015-M871">3</xref>]; the other method is substituting the fluoro with <italic>tert</italic>-butylamine and then transforming to amine in the presence of HCl (<xref ref-type="scheme" rid="molbank-2015-M871-sch001">Scheme 1</xref>). A moderate yield (80.8%.) was obtained for compound <bold>3</bold> using the method without ortho substituted product, which might be ascribed to the steric effect of ester group. The second step is to convert amine to chloro, which could be finished by the conventional Sandmeyer procedure [<xref ref-type="bibr" rid="B4-molbank-2015-M871">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2015-M871">5</xref>] involving initial diazotization of the arylamine followed by addition of the diazonium salt to the cuprous halide in an aqueous solution with the corresponding halogen acid. The satisfactory yields of aryl halides are usually obtained. In the reaction, the target molecule was obtained with a total yield of 44.1%.</p>
    </sec>
    <sec id="sec3-molbank-2015-M871" sec-type="methods">
      <title>3. Experimental</title>
      <sec id="sec3dot1-molbank-2015-M871">
        <title>3.1. General</title>
        <p>The methyl tetrafluorobenzoate, <italic>tert</italic>-butylamine, sodium nitrite, and cuprous chloride were obtained from Sigma-Aldrich (Shanghai, China) and were used without further purification. Melting points were determined using OptiMelt capillary mp apparatus (Sunnyvale, CA, USA) and were uncorrected. NMR spectra were recorded on Bruker Avance 500 MHz instrument (New York, NY, USA) using deuterated DMSO-<italic>d</italic><sub>6</sub> as solvent and tetramethylsilane as internal standard. The IR spectra were recorded on NICOLET Impact 410 instrument (Madison, WI, USA) using KBr pellets. The element analysis was made on a PerkinElmer EA2400 II instrument (Waltham, MA, USA). TLC was carried out using Aladdin pre-coated plates (GF254, 250 &#x3BC;m) (Shanghai, China).</p>
      </sec>
      <sec id="sec3dot2-molbank-2015-M871">
        <title>3.2. Synthesis of 4-Chloro-2,3,5-trifluorobenzoic Acid <italic>(<bold>1</bold>)</italic></title>
        <p>A mixture of methyl tetrafluorobenzoate, <bold>2</bold>, (4.3 g, 17.4 mmol) and <italic>tert</italic>-butylamine (7.1 g, 97.3 mmol) in dry acetonitrile (50 mL) was vigorously stirred at 40 &#xB0;C for 23 h. The reaction progress was monitored by TLC (10% ethyl acetate in hexane). The solvent was removed <italic>in vacuum</italic>. The residue was mixed with water (15 mL) and transferred to a separatory funnel. The mixture was extracted by dichloromethane (3 &#xD7; 10 mL), and the organic layer was washed with water (2 &#xD7; 10 mL), brine (1 &#xD7; 10 mL) and dried over sodium sulfate. Removal of solvent and drying <italic>in vacuum</italic> gave 4.0 g of orange oily product. Then, a mixture of the orange compound (4.0 g) and concentrated hydrochloric acid (37%, 32.0 g) was refluxed for 24 h. The reaction progress was monitored by TLC (10% ethyl acetate in hexane). The reaction mixture was cooled to room temperature and extracted by ethyl acetate (2 &#xD7; 15 mL), and the organic layer was washed with water (2 &#xD7; 10 mL), brine (1 &#xD7; 10 mL) and dried over sodium sulfate. Removal of solvent and drying <italic>in vacuum</italic> gave 2.5 g of white powder (<bold>3</bold>). This mixture was directly used in the next step without further purification. A mixture of the compound <bold>3</bold>, dichloromethane (28 mL), water (10 mL), concentrated hydrochloric acid (37%, 9.4 g) and cuprous chloride (4.2 g, 42.4 mmol) was stirred for 1 h in an ice-salt bath. Sodium nitrite (1.0 g, 14.5 mmol) dissolved in water (8 mL) was dropped into the flask slowly below 5 &#xB0;C. After that, the mixture was stirred under room temperature for another 4 h. The reaction progress was monitored by TLC (10% ethyl acetate in hexane). The reaction mixture was cooled to room temperature and extracted by dichloromethane (2 &#xD7; 10 mL), and the organic layer was washed with Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> solution (10%, 2 &#xD7; 10 mL), HCl solution (5%, 2 &#xD7; 10 mL), decolorizated with activated carbon and dried over sodium sulfate. Removal of solvent and drying <italic>in vacuum</italic> resulted in 1.5 g of off-white powder, which was subjected to column chromatography (SiO<sub>2</sub>) using gradient elution (10% ethyl acetate in hexane, and then elution with 30% ethyl acetate in hexane). The title compound was obtained as a white crystalline solid (1.2 g).</p>
        <p>Yield: 44.1%; m.p.: 82~83 &#xB0;C.</p>
        <p>R<sub>f</sub> (30% ethyl acetate in hexane) = 0.26.</p>
        <p>IR (&#x3BD;, cm<sup>&#x2212;1</sup>): 3101 (O&#x2013;H), 1686 (C=O), 1353 (C&#x2013;F), 905 (C&#x2013;H).</p>
        <p><sup>1</sup>H-NMR (500 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; = 7.75~7.79 (m, 1H), 13.84 (br s, 1H), 7.73~7.78 (m, 1H, D<sub>2</sub>O exchangeable).</p>
        <p><sup>19</sup>F-NMR (564 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; = &#x2212;136.5 (d, <italic>J<sub>H</sub></italic><sub>-<italic>F</italic></sub> = 5.6 Hz, 1F), &#x2212;149.8 (d, <italic>J<sub>H</sub></italic><sub>-<italic>F</italic></sub> = 22.6 Hz, 1F), &#x2212;155.0 (d, <italic>J<sub>H-F</sub></italic> = 22.6 Hz, 1F).</p>
        <p><sup>13</sup>C-NMR(75 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; = 162.5 (s), 145.3~148.8 (q, <italic>J<sub>C-F</sub></italic> = 255.8 Hz), 143.8~147.5 (q, <italic>J<sub>C-F</sub></italic> = 269.6 Hz), 144.1~144.3 (q, <italic>J<sub>C-F</sub></italic> = 12.8 Hz), 138.7~142.4 (m), 140.4~141.9 (m), 113.1~113.4 (q, <italic>J<sub>C-F</sub></italic> = 20.6 Hz).</p>
        <p>ESI-MS: <italic>m</italic>/<italic>z</italic> = 208.9623 (100) [M&#x2212;H]<sup>&#x2212;</sup>, 210.9602 (32).</p>
        <p>Calcd. for C<sub>7</sub>H<sub>2</sub>ClF<sub>3</sub>O<sub>2</sub>, C, 39.93; H, 0.96; Found: C, 39.93; H, 0.92.</p>
        <p><sup>1</sup>H-, <sup>13</sup>C- and <sup>1</sup><sup>9</sup>F-NMR spectra are reported in the <xref ref-type="app" rid="app1-molbank-2015-M871">supplementary materials</xref> as <xref ref-type="app" rid="app1-molbank-2015-M871">Figures S1~S2, S3 and S4</xref>. FTIR spectrum is reported as <xref ref-type="app" rid="app1-molbank-2015-M871">Figure S5</xref> together with ESI-MS spectrum as <xref ref-type="app" rid="app1-molbank-2015-M871">Figure S6</xref>.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2015-M871">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2015-M871-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M871-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2015-M871-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M871-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2015-M871-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M871-s002.pdf">
   <label>Supplementary File 3</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>Authors are thankful to China Pharmaceutical University for providing the spectra data. </p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>Shuitao Yu, Yang Chen: Literature search and experimental synthetic work; Xiaohu Feng, Zhengjun Xia, Mingguang Zhang, Weiyou Zhou: HPLC, IR and NMR and MS interpretation, writing of manuscript; Zaixin Chen: Design of synthesis.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2015-M871">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kawakami</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Motomura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Aramaki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Matsuzaki</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yamataka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors</article-title>
          <source>J. Med. Chem.</source>
          <year>2009</year>
          <volume>52</volume>
          <fpage>4869</fpage>
          <lpage>4882</lpage>
          <pub-id pub-id-type="doi">10.1021/jm900460z</pub-id>
          <pub-id pub-id-type="pmid">19719237</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2015-M871">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashfaq</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>S.S.A.</given-names>
            </name>
            <name>
              <surname>Najam</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ahmad</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Tabassum</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Synthetic Thioamide, Benzimidazole, Quinolone and Derivatives with Carboxylic Acid and Ester Moieties: A Strategy in the Design of Antituberculosis Agents</article-title>
          <source>Curr. Med. Chem.</source>
          <year>2014</year>
          <volume>21</volume>
          <fpage>911</fpage>
          <lpage>931</lpage>
          <pub-id pub-id-type="doi">10.2174/09298673113206660302</pub-id>
          <pub-id pub-id-type="pmid">24164193</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2015-M871">
        <label>3.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Lesher</surname>
              <given-names>G.Y.</given-names>
            </name>
          </person-group>
          <article-title>Tricyclic-Pyridinylquinoline Compounds, Their Preparation and Use</article-title>
          <source>U.S. Patent</source>
          <patent>4839355 A</patent>
          <day>13</day>
          <month>June</month>
          <year>1989</year>
        </citation>
      </ref>
      <ref id="B4-molbank-2015-M871">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hodgson</surname>
              <given-names>H.H.</given-names>
            </name>
          </person-group>
          <article-title>The sandmeyer reaction</article-title>
          <source>Chem. Rev.</source>
          <year>1947</year>
          <volume>40</volume>
          <fpage>251</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="doi">10.1021/cr60126a003</pub-id>
          <pub-id pub-id-type="pmid">20291034</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2015-M871">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berrouard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Dufresne</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pron</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Veilleux</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Leclerc</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Low-cost synthesis and physical characterization of thieno[3,4-c]pyrrole-4,6-dione-based polymers</article-title>
          <source>J. Org. Chem.</source>
          <year>2012</year>
          <volume>77</volume>
          <fpage>8167</fpage>
          <lpage>8173</lpage>
          <pub-id pub-id-type="doi">10.1021/jo301512e</pub-id>
          <pub-id pub-id-type="pmid">22946845</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2015-M871-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2015-M871-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of 4-chloro-2,3,5-trifluorobenzoic acid.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M871-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
